Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0000899243-21-033505

Director bought 50,000 shares at an average $2.76 ($138,188)

From the SEC's structured data for this filing

Trades in this filing

ARMISTICE CAPITAL, LLC · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-16 Purchase : show line 1 in the form +30,000 $2.75 $82,638 39,280,000 I
2021-08-18 Purchase : show line 2 in the form +20,000 $2.78 $55,550 39,300,000 I
Open-market purchases · 50,000 sh · avg $2.76 · $138,188
Loading xslF345X03/doc4.xml…